ASCENTIA HEARTSTATION ECG MANAGEMENT SYSTEM— 510(k) K050858

Name: FDA 510(k) clearance K050858
Creator: U.S. Food and Drug Administration
Published: 2005-06-29

Substantially Equivalent

Heartlab, Inc.

FDA 510(k) clearance K050858 for ASCENTIA HEARTSTATION ECG MANAGEMENT SYSTEM, Substantially Equivalent on 2005-06-29. Applicant: Heartlab, Inc.. Device class: 2.

Clearance details

Applicant: Heartlab, Inc.
Product code: Code DPS
Device class: Class 2
Regulation: 21 CFR 870.2340
Advisory panel: Cardiovascular
Date received: 2005-04-05
Decision date: 2005-06-29
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: Westerly, RI, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DPS

view all

K252463 — SE-1202 Series Electrocardiograph (Model: SE-1202, SE-1202E)2026-07-02
K251670 — MAC 7 Resting ECG Analysis System2026-01-26
K252361 — AccurECG Analysis System (v2.0)2025-12-22
K252474 — Withings BeamO (SCT02)2025-11-10
K250569 — Cardiologs Holter Platform2025-08-06

More clearances from Heartlab, Inc.

view all

K050228 — AGFA HEARTLAB CARDIOVASCULAR2005-02-18
K042042 — ULTRASOUND CAPTURE SYSTEM2004-09-21
K040896 — MODIFICATION TO ENCOMPASS2004-07-16
K954479 — DICOMVIEW1996-02-21
K954860 — ECHONET1995-12-21

Adverse events under product code DPS

product code DPS

Death: 7
Total: 7

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.